These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25829375)

  • 1. Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.
    Mondelli V; Ciufolini S; Belvederi Murri M; Bonaccorso S; Di Forti M; Giordano A; Marques TR; Zunszain PA; Morgan C; Murray RM; Pariante CM; Dazzan P
    Schizophr Bull; 2015 Sep; 41(5):1162-70. PubMed ID: 25829375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment.
    Mondelli V; Dazzan P; Hepgul N; Di Forti M; Aas M; D'Albenzio A; Di Nicola M; Fisher H; Handley R; Marques TR; Morgan C; Navari S; Taylor H; Papadopoulos A; Aitchison KJ; Murray RM; Pariante CM
    Schizophr Res; 2010 Feb; 116(2-3):234-42. PubMed ID: 19751968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological stress response in women at risk of postpartum psychosis: The role of life events and inflammation.
    Aas M; Vecchio C; Pauls A; Mehta M; Williams S; Hazelgrove K; Biaggi A; Pawlby S; Conroy S; Seneviratne G; Mondelli V; Pariante CM; Dazzan P
    Psychoneuroendocrinology; 2020 Mar; 113():104558. PubMed ID: 31923613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse.
    Ciufolini S; Gayer-Anderson C; Fisher HL; Marques TR; Taylor H; Di Forti M; Zunszain P; Morgan C; Murray RM; Pariante CM; Dazzan P; Mondelli V
    Schizophr Res; 2019 Mar; 205():38-44. PubMed ID: 29776641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis.
    Belvederi Murri M; Pariante CM; Dazzan P; Hepgul N; Papadopoulos AS; Zunszain P; Di Forti M; Murray RM; Mondelli V
    Psychoneuroendocrinology; 2012 May; 37(5):629-44. PubMed ID: 21930345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis.
    Labad J; Armario A; Nadal R; Solé M; Gutiérrez-Zotes A; Montalvo I; Moreno-Samaniego L; Martorell L; Sánchez-Gistau V; Vilella E
    Psychiatry Res; 2018 Jul; 265():284-291. PubMed ID: 29775885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis.
    Dunleavy C; Elsworthy RJ; Upthegrove R; Wood SJ; Aldred S
    Acta Psychiatr Scand; 2022 Jul; 146(1):6-20. PubMed ID: 35202480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal cortisol variation and cortisol response to an MRI stressor in schizophrenia and bipolar disorder.
    Girshkin L; O'Reilly N; Quidé Y; Teroganova N; Rowland JE; Schofield PR; Green MJ
    Psychoneuroendocrinology; 2016 May; 67():61-9. PubMed ID: 26874562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral immune markers and antipsychotic non-response in psychosis.
    Enache D; Nikkheslat N; Fathalla D; Morgan BP; Lewis S; Drake R; Deakin B; Walters J; Lawrie SM; Egerton A; MacCabe JH; Mondelli V
    Schizophr Res; 2021 Apr; 230():1-8. PubMed ID: 33667853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and gene expression profile of cytokines in first-episode psychosis.
    Di Nicola M; Cattaneo A; Hepgul N; Di Forti M; Aitchison KJ; Janiri L; Murray RM; Dazzan P; Pariante CM; Mondelli V
    Brain Behav Immun; 2013 Jul; 31():90-5. PubMed ID: 22749891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin.
    Labad J; Stojanovic-Pérez A; Montalvo I; Solé M; Cabezas Á; Ortega L; Moreno I; Vilella E; Martorell L; Reynolds RM; Gutiérrez-Zotes A
    J Psychiatr Res; 2015 Jan; 60():163-9. PubMed ID: 25466832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.
    Chiappelli J; Shi Q; Kodi P; Savransky A; Kochunov P; Rowland LM; Nugent KL; Hong LE
    Psychoneuroendocrinology; 2016 Jan; 63():86-93. PubMed ID: 26431803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment.
    Corsi-Zuelli F; Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Louzada-Junior P; Mondelli V; Del-Ben CM
    Psychol Med; 2020 May; 50(7):1139-1147. PubMed ID: 31064423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
    Nordholm D; Rostrup E; Mondelli V; Randers L; Nielsen MØ; Wulff S; Nørbak-Emig H; Broberg BV; Krakauer K; Dazzan P; Zunszain PA; Nordentoft M; Glenthøj B
    Psychoneuroendocrinology; 2018 Jun; 92():72-80. PubMed ID: 29635174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted cortisol awakening response in men with first episode psychosis: relationship to parental bonding.
    Pruessner M; Vracotas N; Joober R; Pruessner JC; Malla AK
    Psychoneuroendocrinology; 2013 Feb; 38(2):229-40. PubMed ID: 22770984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted cortisol awakening response in people at ultra high risk of developing psychosis.
    Day FL; Valmaggia LR; Mondelli V; Papadopoulos A; Papadopoulos I; Pariante CM; McGuire P
    Schizophr Res; 2014 Sep; 158(1-3):25-31. PubMed ID: 25048422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical folding defects as markers of poor treatment response in first-episode psychosis.
    Palaniyappan L; Marques TR; Taylor H; Handley R; Mondelli V; Bonaccorso S; Giordano A; McQueen G; DiForti M; Simmons A; David AS; Pariante CM; Murray RM; Dazzan P
    JAMA Psychiatry; 2013 Oct; 70(10):1031-40. PubMed ID: 23945954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-α, IFN-γ, ΤNF-β, IL-4 deviation.
    Karanikas E; Manganaris S; Ntouros E; Floros G; Antoniadis D; Garyfallos G
    Asian J Psychiatr; 2017 Apr; 26():99-103. PubMed ID: 28483103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.